HCID 86636977, compound → HCID 86636976, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([N:32]2[CH2:38][CH:37]([N:39]([CH3:41])[CH3:40])[C:34]3([CH2:36][CH2:35]3)[CH2:33]2)[C:5]([F:31])=[C:6]([NH:8][NH:9][C:10](=[O:30])[C@H:11]([CH2:24][CH:25]2[CH2:29][CH2:28][CH2:27][CH2:26]2)[CH2:12][N:13]([O:16]CC2C=CC=CC=2)[CH:14]=[O:15])[CH:7]=1>CO.[Rh]>[Cl:1][C:2]1[CH:3]=[C:4]([N:32]2[CH2:38][CH:37]([N:39]([CH3:41])[CH3:40])[C:34]3([CH2:36][CH2:35]3)[CH2:33]2)[C:5]([F:31])=[C:6]([NH:8][NH:9][C:10](=[O:30])[C@H:11]([CH2:24][CH:25]2[CH2:26][CH2:27][CH2:28][CH2:29]2)[CH2:12][N:13]([OH:16])[CH:14]=[O:15])[CH:7]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
[(2R)-3-(2-{5-Chloro-3-[7-(dimethylamino)-5-azaspiro[2.4]hept-5-yl]-2-fluorophenyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl][(phenylmethyl)oxy]formamide (300 mg, 0.51 mmol) was dissolved in 5 mL of MeOH. 5% Rhodium on Alumina (240 mg) was added, and the contents were stirred under a hydrogen balloon overnight. The contents were then filtered to remove the catalyst, and the filtrate was concentrated in vacuo. The resulting crude product was purified via reverse phase HPLC to provide [(2R)-3-(2-{5-chloro-3-[7-(dimethylamino)-5-azaspiro[2.4]hept-5-yl]-2-fluorophenyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl]hydroxyformamide (single unknown diastereomer) (142 mg, 56%). LCMS: (M+H)+: 498.3.
Workup
- filtrationThe contents were then filtered
- customto remove the catalyst
- concentrationthe filtrate was concentrated in vacuo
- customThe resulting crude product was purified via reverse phase HPLC
Sources & evidence
- ORD record
- ord-6d8c33e75dc64fb397a526d6fa34e2a1
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07893056B2
Reaction notes
Loading…